ClouDr Group Limited (HKG:9955)
Hong Kong · Delayed Price · Currency is HKD 0.4000
-0.0050 (-1.23%)
Oct 22, 2026, 4:08 PM HKT
ClouDr Group Revenue
ClouDr Group had revenue of 629.23M CNY in the half year ending June 30, 2026, a decrease of -70.39%. This brings the company's total for the last twelve months to 1.36B, down -39.72% year-over-year. In the year 2025, ClouDr Group had annual revenue of 1.62B, down -53.47%. That makes ClouDr Group the 17,471st largest company in the world by revenue and 1,010th in Hong Kong.
Revenue (ttm)
1.36B CNY
Revenue Growth
-39.72%
P/S Ratio
0.17
Revenue / Employee
1.75M CNY
Employees
776
Market Cap
258.29M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.62B | -1.86B | -53.47% |
| Dec 31, 2024 | 3.49B | -202.44M | -5.49% |
| Dec 31, 2023 | 3.69B | 702.48M | 23.51% |
| Dec 31, 2022 | 2.99B | 1.23B | 70.09% |
| Dec 31, 2021 | 1.76B | 917.61M | 109.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 660.27B |
| Charmacy Pharmaceutical | 5.40B |
| ETHK Labs | 3.35B |
| Sinco Pharmaceuticals Holdings | 2.22B |
| Sipai Health Technology | 1.83B |
| 160 Health International | 784.99M |
| Ziyuanyuan Holdings Group | 423.08M |
| Wanjia Group Holdings | 165.39M |
ClouDr Group News
- 3 months ago - ClouDr Group Earnings release: H1 2026 - Filings
- 3 months ago - ClouDr Group Quarterly report: H1 2026 - Filings
- 9 months ago - ClouDr Group Earnings release: H2 2025 - Filings
- 9 months ago - ClouDr Group Annual report: H2 2025 - Filings